Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fengli Yuan"'
Autor:
Xuxiu Lu, Fengli Yuan, Liang Qiao, Yankai Liu, Qianqun Gu, Xin Qi, Jing Li, Dehai Li, Ming Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116099- (2024)
Chronic myelogenous leukemia (CML) is characterized by the constitutive activation of BCR-ABL tyrosine kinase. Imatinib was approved for CML therapy, however, BCR-ABL-dependent drug resistance, especially BCR-ABL-T315I mutation, restricts its clinica
Externí odkaz:
https://doaj.org/article/a8b9fde1598844f3b1be00692991224c
Autor:
Fengli Yuan, Liang Qiao, Yinghan Chen, Xin Qi, Yankai Liu, Dehai Li, Qianqun Gu, Jing Li, Ming Liu
Publikováno v:
Marine Drugs, Vol 15, Iss 11, p 346 (2017)
AS1041 is a novel synthesized anthraquinone lactone derivative of marine natural compound aspergiolide A (ASP-A) with new structure skeleton and marked cytotoxicity in cancer cells. To study its cytotoxicity in detail, we evaluated its activity on hu
Externí odkaz:
https://doaj.org/article/4c0e97458a8544d9841f841bde7ef15c
Autor:
Jing Li, Yan-Kai Liu, Ming Liu, Qianqun Gu, Dehai Li, Ying-Han Chen, Liang Qiao, Fengli Yuan, Xin Qi
Publikováno v:
Marine Drugs, Vol 15, Iss 11, p 346 (2017)
Marine Drugs
Marine Drugs; Volume 15; Issue 11; Pages: 346
Marine Drugs
Marine Drugs; Volume 15; Issue 11; Pages: 346
AS1041 is a novel synthesized anthraquinone lactone derivative of marine natural compound aspergiolide A (ASP-A) with new structure skeleton and marked cytotoxicity in cancer cells. To study its cytotoxicity in detail, we evaluated its activity on hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d765f8eb87a6f7b67cfde0b985d31bae
https://www.mdpi.com/1660-3397/15/11/346
https://www.mdpi.com/1660-3397/15/11/346